BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 530258)

  • 1. Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.
    Sjöholm I; Ekman B; Kober A; Ljungstedt-Påhlman I; Seiving B; Sjödin T
    Mol Pharmacol; 1979 Nov; 16(3):767-77. PubMed ID: 530258
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of hepatic cirrhosis on the plasma protein binding of drugs.
    García-Morillas M; Gil-Extremera B; Caracuel-Ruiz MD
    Int J Clin Pharmacol Res; 1984; 4(5):327-33. PubMed ID: 6519849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin.
    Wosilait WD; Ryan MP
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):577-84. PubMed ID: 504792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The location of drug binding sites in human serum albumin.
    Fehske KJ; Müller WE; Wollert U
    Biochem Pharmacol; 1981 Apr; 30(7):687-92. PubMed ID: 7018498
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural requirements for drug binding to site II on human serum albumin.
    Wanwimolruk S; Birkett DJ; Brooks PM
    Mol Pharmacol; 1983 Nov; 24(3):458-63. PubMed ID: 6195516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.
    Kragh-Hansen U; Brennan SO; Galliano M; Sugita O
    Mol Pharmacol; 1990 Feb; 37(2):238-42. PubMed ID: 2304452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lone tryptophan residue of human serum albumin as part of the specific warfarin binding site. Binding of dicoumarol to the warfarin, indole and benzodiazepine binding sites.
    Fehske KJ; Müller WE; Wollert U; Velden LM
    Mol Pharmacol; 1979 Nov; 16(3):778-89. PubMed ID: 93690
    [No Abstract]   [Full Text] [Related]  

  • 11. Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.
    Benkestock K; Edlund PO; Roeraade J
    Rapid Commun Mass Spectrom; 2005; 19(12):1637-43. PubMed ID: 15915474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New aspects of free drug concentration determination in human serum with equilibrium dialysis.
    van der Giesen WF; Wilting J
    Methods Find Exp Clin Pharmacol; 1982; 4(6):417-23. PubMed ID: 7144334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fatty acids on two specific drug binding sites on human serum albumin.
    Birkett DJ; Myers SP; Sudlow G
    Mol Pharmacol; 1977 Nov; 13(6):987-92. PubMed ID: 593269
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct and indirect determination of binding constants of drug-protein complexes with microparticles.
    Kober A; Ekman B; Sjöholm I
    J Pharm Sci; 1978 Jan; 67(1):107-9. PubMed ID: 619095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy. Binding of drugs to serum albumin (second of two parts).
    Koch-Weser J; Sellers EM
    N Engl J Med; 1976 Mar; 294(10):526-31. PubMed ID: 765821
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasma binding of drugs in chronic renal failure].
    Riant P; Barre J; Albengres E; Lemaire M; Tillement JP
    Nephrologie; 1986; 7(3):89-93. PubMed ID: 3774085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein binding of diazepam and digitoxin in uremic and normal serum.
    Kober A; Sjöholm I; Borgå O; Odar-Cederlöf I
    Biochem Pharmacol; 1979 Apr; 28(7):1037-42. PubMed ID: 444260
    [No Abstract]   [Full Text] [Related]  

  • 19. Binding of drugs to serum albumin (first of two parts).
    Koch-Weser J; Sellers EM
    N Engl J Med; 1976 Feb; 294(6):311-6. PubMed ID: 1107839
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography.
    Chen J; Ohnmacht C; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):137-45. PubMed ID: 15282104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.